Sonaflam

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sonaflam

What Type of Medicine is Sonaflam?

Sonaflam is a trade name for a medication whose active constituent is Naproxen Sodium, officially classified as a Non-steroidal anti-inflammatory drug (NSAID). This synthetic compound is chemically defined as a propionic acid derivative, placing it in a group of agents recognized for their ability to manage pain and swelling. The drug is a single-ingredient product designed for systemic relief, signifying that its action is distributed throughout the body. Its identity as an NSAID defines its primary role in modulating inflammatory processes.

Composition and Physical Form (Tablet)

The functional core of Sonaflam is Naproxen Sodium, which is provided as a film-coated tablet intended for oral administration. A key characteristic of this formulation is the inclusion of the sodium salt component, which is used to enhance the compound's dissolution rate, facilitating a more rapid onset of absorption compared to the base naproxen acid formulation. As a solid dosage form, the tablet ensures a precise, standardized dose of the active substance is ingested, supporting its function in addressing physical discomfort.

Sonaflam's General Symptomatic Purpose

The overall purpose of Naproxen Sodium is to provide relief from three primary symptoms: pain, inflammation, and fever. It exerts these effects by acting as a cyclooxygenase inhibitor, a mechanism that reduces the body's synthesis of prostaglandins, which are chemical mediators responsible for promoting the inflammatory response. This action provides a combined analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) effect. This medication is typically used when symptomatic relief is required for general discomfort or swelling, offering a non-narcotic option for managing the physical manifestations of irritation or injury.

What side effects are possible with Sonaflam?

Serious and Clinically Significant Risks

Regulatory authorities document that Sonaflam, like other non-steroidal anti-inflammatory drugs (NSAIDs), carries a risk of serious, potentially fatal, adverse events affecting major body systems. These risks may increase with the duration of use and higher doses.

  • Cardiovascular Thrombotic Events: An increased risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke, is documented. The risk is higher in patients with pre-existing heart disease or associated risk factors. Sonaflam is generally contraindicated following coronary artery bypass graft (CABG) surgery.
  • Gastrointestinal Events: Serious gastrointestinal adverse events, such as bleeding, ulceration, and perforation of the stomach or intestines, can occur without warning symptoms and may be fatal. Elderly patients and those with a history of gastrointestinal disease are at greater risk.

Adverse Reactions and Systemic Concerns

Adverse reactions span multiple system-organ classes, including the nervous system (e.g., headache, dizziness, drowsiness), gastrointestinal system (e.g., nausea, vomiting, indigestion, diarrhea), and skin.

  • Allergic Reactions: Severe hypersensitivity reactions are documented, including anaphylaxis and serious skin reactions such as Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms).
  • Hepatic and Renal Toxicity: Liver damage, which can lead to severe hepatitis or liver failure, and kidney toxicity, including renal papillary necrosis and acute renal failure, are reported and require function monitoring in at-risk patients.

Safety-Related Limitations

Sonaflam is generally contraindicated in patients with active gastrointestinal bleeding or ulcers, known hypersensitivity to the drug or other NSAIDs, uncontrolled high blood pressure, and advanced kidney or liver failure. Use during the third trimester of pregnancy is restricted due to risks to the fetus.

Overdose and Emergency Response

Overdose and When to Seek Help

Immediate Medical Attention Required

Seek immediate medical attention for any known or suspected ingestion of an amount of Sonaflam exceeding the prescribed maximum dose. Regulatory authorities mandate that you contact emergency services or a national poison help center right away, even if initial symptoms are not yet apparent. This action is required due to the potential for serious, life-threatening outcomes associated with overdosage.

Documented Clinical Manifestations

The documented presentations of Naproxen Sodium overdose may initially involve common effects such as nausea, vomiting, epigastric pain, drowsiness, dizziness, and tinnitus (ringing in the ears). In cases of massive overdosage, manifestations of severe systemic toxicity may include convulsions (seizures), coma, gastrointestinal hemorrhage, and acute renal failure.

Official Overdose Management

Official regulatory information states explicitly that no specific antidote is known for acute Naproxen Sodium toxicity. Management is strictly symptomatic and supportive. Hospital monitoring is required, often involving continuous assessment of vital signs and laboratory tests to address severe complications, correct fluid imbalances, and manage metabolic abnormalities. Official labeling notes that elderly patients and those with pre-existing kidney or liver disease are at heightened risk for serious toxic effects.

Therapeutic Uses of Sonaflam

The primary therapeutic utility of Sonaflam (Naproxen Sodium) is to offer symptomatic relief across key domains where discomfort, inflammation, and fever create symptoms that interfere with daily functioning. In clinical settings marked by heightened patient distress, this medication is used to help manage difficult symptomatic episodes.

Key Therapeutic Applications

Sonaflam is commonly used across conditions characterized by periods of heightened symptoms within the musculoskeletal system, such as osteoarthritis and rheumatoid arthritis, and for acute events like sprains, strains, or tendinitis. It is also relevant for easing acute pain following dental procedures or minor surgery, and for addressing the episodic manifestations of migraine headache attacks, as well as the cyclical, cramping pain associated with primary dysmenorrhea. This support may assist with maintaining functional stability and contributes to easing the overall symptom load.

The core therapeutic aim is described as: “It is commonly used to help with the pain, swelling, and fever associated with inflammatory or irritative states.”

Systemic Symptom Stabilization

The medication is relevant in contexts marked by increased discomfort or tension, applied in addressing symptoms related to systemic imbalance. It may assist with lowering fever and is relevant for easing the generalized aches and pain associated with conditions like the cold or flu. This application supports general well-being during symptomatic phases.

Quick Fact: Symptomatic Support for Joint Stiffness Sonaflam is considered relevant for managing pain and inflammation that cause joint stiffness, which may help patients cope more steadily with symptom fluctuations.

Regulatory References

  1. MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility to use Sonaflam (Naproxen Sodium) is strictly defined by official regulatory documents based on a patient’s health status and life stage. The most stringent limits are contraindications, which prohibit use entirely.

Contraindicated Populations

Sonaflam is contraindicated and must not be used by patients with:

  • A history of severe allergic reactions to aspirin or other NSAIDs.
  • Severe organ failure, including severe heart, hepatic, or renal impairment.
  • Active gastrointestinal bleeding or recurrent peptic ulceration.
  • Pain following Coronary Artery Bypass Graft (CABG) surgery.
  • The third trimester of pregnancy (at or after 30 weeks gestation).

Restricted and Conditional Use

Use is restricted and requires caution for older adults and individuals with mild to moderate renal or hepatic impairment. Safety and efficacy are not established for general use in children younger than 16 years of age, though specific use is permitted for Juvenile Rheumatoid Arthritis. Use is generally avoided during lactation.

What should I know about interactions with other medicines?

Sonaflam (Naproxen Sodium) has officially documented interaction patterns that necessitate careful consideration upon co-administration. Regulatory documents classify the use of Sonaflam as contraindicated for treating pain immediately following Coronary Artery Bypass Graft (CABG) surgery. Co-administration with other Non-steroidal Anti-inflammatory Drugs (NSAIDs) is not generally recommended due to an increased risk of serious adverse effects.

The interaction profile is structured around two primary concerns: exposure modification and additive effects. Sonaflam may increase the systemic exposure of several co-administered medicines by reducing their clearance, including Lithium, Methotrexate, and Digoxin. Agents that inhibit the CYP2C9 enzyme, such as Fluconazole, may also cause Naproxen concentrations to increase. Probenecid is also documented to increase Naproxen exposure.

A key pharmacodynamic interaction is the additive bleeding risk when Sonaflam is combined with agents like Warfarin, Antiplatelet Agents, Corticosteroids, and SSRIs/SNRIs. Additionally, the consumption of alcohol is officially associated with an increased risk of gastrointestinal bleeding.

Sonaflam may also diminish the therapeutic effect of certain medications, including ACE Inhibitors, ARBs, and Diuretics. In high-risk populations, such as the elderly or those with existing kidney impairment, the combination with ACE Inhibitors or ARBs may lead to a deterioration of renal function. Regulatory information also notes that administering certain antacids or Cholestyramine is not recommended as it may interfere with drug absorption.

Mechanism of Action

Sonaflam (Naproxen Sodium) modulates specific biochemical pathways and enzyme activity that mediate physiological responses.

Blocking Prostaglandin Synthesis at the Enzyme Level

The mechanism begins with the reversible inhibition of the Cyclooxygenase (COX) enzymes, specifically targeting both COX-1 and COX-2. This action disrupts the conversion of arachidonic acid into prostaglandins—key mediators involved in physiological responses like nociception and vascular permeability. Limiting the synthesis of these chemical signals initiates a cascade that modulates the activity of downstream physiological pathways.

Modulating Nociceptive Pathways and Central Thermoregulation

The reduced presence of prostaglandins leads to a physiological outcome across two key systems: peripheral nociceptive pathways and central thermoregulation. In peripheral tissues, fewer prostaglandins prevent the sensitization of afferent nerve endings to chemical irritants. Centrally, the mechanism prevents PGE2 from artificially elevating the hypothalamic thermal set-point, maintaining the set-point at its homeostatic level.

Mechanism Speed Enhancement (Sodium Salt)

The use of the sodium salt component in this formulation is a mechanism-dependent factor that influences the absorption kinetics of the compound. The salt significantly increases the compound's dissolution rate and absorption speed from the gut, facilitating a more rapid systemic onset of the enzyme-inhibiting action through enhanced dissolution and absorption.

Dosage and Administration Information

Official Administration Guidelines for Sonaflam (Naproxen Sodium)

The official instructions for Sonaflam, a Naproxen Sodium formulation, structure its use based on the lowest effective dose for the shortest duration necessary to manage symptoms. The drug is approved for oral administration in the form of tablets or suspension.

Administration Scope Official Labeled Instruction
Route of Administration Oral (swallowed tablet or liquid suspension).
Dosing Schedule (Chronic) 500 mg to 1000 mg total daily dose (Naproxen base equivalent), typically administered in two divided doses.
Dosing Schedule (Acute) Initial dose up to 1375 mg on the first day, followed by a total daily dose not exceeding 1100 mg.
Timing in Relation to Meals Should be taken with or immediately after food or milk.
Preparation Requirements Standard and immediate-release tablets are taken with a full glass of water. Delayed-release forms must not be crushed or chewed.
Age-Group Administration Older adults should be started on the lowest effective dose. Pediatric dosing (for Juvenile Idiopathic Arthritis in children over 5 years) is based on 10 mg/kg body weight, divided into two daily doses.
Missed-Dose Rules Take the missed dose as soon as remembered; however, if it is almost time for the next scheduled dose, the missed dose should be skipped.

This procedural structure ensures standardized use of the medication. For long-term use, the prescribed frequency pattern is generally twice daily (every 12 hours) for consistent systemic exposure, while acute treatment allows for an as-needed schedule within specified daily limits. All administration must follow the label's condition of using the lowest quantity for the shortest duration.

Recent Clinical Evidence

Sonaflam: Recent Clinical Evidence


Clinical Evidence for Symptom Management

Research has examined Sonaflam (Naproxen Sodium) for conditions marked by functional limitations, such as osteoarthritis and rheumatoid arthritis. Studies typically use Randomized Controlled Trials (RCTs) to monitor patient-reported outcomes related to pain, joint stiffness, and daily functioning over short periods, usually one to four weeks. The aggregated data describe patterns related to measured changes in pain and functional scales during these limited study periods.

For acute or disruptive episodes, including musculoskeletal injuries (sprains, strains) and acute pain (such as post-operative or primary dysmenorrhea), the evidence relies on single-dose and short-term RCTs. These studies primarily focus on immediate effects, assessing the degree of reported pain change and the time intervals over which changes in pain were observed. This research provides insight into short-term changes but focuses only on the initial treatment phase.


Research Scope and Limitations

A consistent finding across the research is that long-term effects are not fully established beyond the initial trial periods. Evidence for use exceeding a few weeks primarily comes from observational settings evaluating daily-life functioning, with fewer controlled, multi-year trials available. These observational studies help show what has been observed so far but do not offer the same certainty as long-term RCTs regarding sustained effects or symptom recurrence.

The agent was observed in specific populations where dedicated research or subgroup analyses have been performed, including older adults (aged ≥ 65 years) and adolescents (aged ≥ 12 years) in certain acute pain contexts. However, data for certain groups remain insufficient, especially for populations with multiple existing health conditions. The overall research landscape clarifies that follow-up durations were limited across many indications, and certainty remains low in areas where findings were mixed or the data are still emerging.

Key Studies & References

  1. Naproxen Sodium Tablet Prescribing Information (DailyMed)
  2. Naproxen (Oral Route) - Drug Information (MedlinePlus)

Frequently Asked Questions (FAQ)

Common questions about Sonaflam (FAQ)


Q: Can Sonaflam be taken on an empty stomach?

Official administration instructions describe taking Sonaflam with or immediately after food or milk. This timing is specified to help reduce the possibility of stomach-related adverse effects, such as irritation or discomfort, as noted in the product information.


Q: Can Sonaflam affect my blood pressure?

Regulatory documents indicate that Sonaflam may cause new cases of high blood pressure (hypertension) or worsen pre-existing high blood pressure. Official information also notes that Sonaflam may diminish the therapeutic effect of certain medications used to treat high blood pressure, such as ACE inhibitors.


Q: Does Sonaflam interact with alcohol consumption?

Official warnings clearly indicate that the consumption of alcohol while using Sonaflam is associated with an increased risk of gastrointestinal bleeding. This association with gastrointestinal bleeding is noted in the official product information.


Q: Can people with kidney issues use Sonaflam?

Sonaflam is strictly contraindicated for patients with severe kidney impairment. For individuals with mild to moderate kidney issues, official documents note that use is restricted and requires careful function monitoring due to the potential risk of renal function deterioration.


Q: Can Sonaflam be taken at the same time as cold and flu medicine?

Regulatory information advises against taking Sonaflam alongside other non-steroidal anti-inflammatory drugs (NSAIDs) because it may lead to an increased risk of serious adverse effects. Since many over-the-counter cold and flu medicines may contain an NSAID ingredient, it is important to be aware of this potential interaction.


Q: Can Sonaflam be broken in half before swallowing?

Official guidelines specify that certain forms of the medication, such as delayed-release tablets, must not be crushed or chewed. The preparation of tablets is described according to the specific official labeling for the product form.


Q: Can using Sonaflam for a long period cause any major problems?

Regulatory authorities document that the risks of serious adverse events—including cardiovascular issues like heart attack and stroke, and gastrointestinal bleeding—may increase with the duration of use. Reports also include potential liver and kidney toxicity. Official administration guidelines describe using the lowest effective dose for the shortest duration.


Q: Does Sonaflam cause drowsiness?

Adverse reactions documented for Sonaflam include effects on the nervous system, such as headache, dizziness, and drowsiness. These effects are listed as documented adverse reactions noted in official medical information.


Q: Are there any specific foods or drinks I should avoid while using Sonaflam?

Official product information notes that alcohol consumption is associated with an increased risk of gastrointestinal bleeding. Additionally, certain types of antacids or a medication called Cholestyramine are noted to potentially interfere with the drug's absorption into the body.


Q: How long does Sonaflam stay in your system after the last use?

The drug is documented to have an elimination half-life of approximately 12 to 17 hours. This means that about half of the dose is removed from the system during that time interval, with the full elimination taking longer.


Q: Is it common to experience stomach discomfort when first starting Sonaflam?

Gastrointestinal adverse reactions such as nausea, vomiting, indigestion, and diarrhea are among the effects documented in official information. Taking Sonaflam with food or milk is intended to help mitigate stomach irritation.


Q: What is the evidence regarding Sonaflam's use for chronic conditions?

Research has examined Sonaflam for chronic conditions like osteoarthritis and rheumatoid arthritis using short-term controlled studies. These trials monitor patient outcomes such as pain and daily functioning. Official documentation notes that long-term effects beyond a few weeks are not fully established in these controlled trials.


Q: Is Sonaflam the same as a steroid?

Sonaflam is officially classified as a Non-steroidal anti-inflammatory drug (NSAID). This classification is used to distinguish its pharmacological class from corticosteroid medications.


Q: What are the most commonly reported less serious side effects of Sonaflam?

Official documents describe a wide range of adverse reactions across multiple system-organ classes. Some of the frequently reported effects include headache, dizziness, nausea, and indigestion, which are noted in the adverse reactions section of the drug information.


Q: Does Sonaflam cause changes in mood or sleep?

Documented adverse reactions include effects on the nervous system such as drowsiness and dizziness. Official documents also describe reports of sleep disturbance, such as insomnia, and mood-related changes.


Q: Are there different strengths of Sonaflam available?

Sonaflam is supplied in different strengths for oral administration, which may include 275 mg and 550 mg film-coated tablets. The specific strengths available can depend on the local regulatory classification (e.g., prescription or over-the-counter).


Q: Can I drive or operate machinery after taking Sonaflam?

Due to documented adverse effects like dizziness, drowsiness, and fatigue, official regulatory information carries a warning about performing tasks that require mental alertness. These tasks include driving or operating machinery.


Q: Is it true that Sonaflam can affect fertility?

Official documents may contain a caution noting that, based on its mechanism of action, Sonaflam is documented to potentially impair female fertility. This effect is documented in official information as being reversible upon discontinuation of the medication.


Q: Does Sonaflam require a prescription, or is it available over the counter?

Sonaflam is generally available in different regulatory classes. Higher strengths are typically classified as prescription-only, while lower strengths may be available over the counter (OTC), depending on the country's local regulatory decision.


Q: Is it normal to feel dizzy or lightheaded after taking Sonaflam?

Dizziness and lightheadedness are documented adverse effects of Sonaflam that affect the nervous system. The occurrence of such effects is a reported reaction noted in official medical information.


Q: Are there specific instructions for stopping Sonaflam use?

Official guidelines for Sonaflam administration describe using the lowest effective dose for the shortest duration. For short-term use, specific tapering instructions are generally not required, but the management of discontinuation for extended use is typically guided by established clinical practices.


Q: What is the general expectation for improvement when using Sonaflam?

The formulation is designed for a more rapid systemic onset of action due to the sodium salt component, which promotes rapid absorption. Clinical research assesses the degree of reported pain change and the time intervals over which changes are typically observed in the initial treatment phase.

How should Sonaflam be stored and disposed of?

Storage and Disposal Requirements

Sonaflam (Naproxen Sodium) tablets must be stored according to strict official guidelines to maintain product stability and ensure safety.

Requirement Official Regulatory Mandate
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep in the original container, which must be tightly closed to protect from moisture and excessive heat.
Child Safety Must be stored out of the sight and reach of children.

Official disposal instructions recommend using a drug take-back program for unused or expired medicine. If a program is unavailable, follow specific regulatory instructions for household trash disposal, which involves mixing the tablets with an undesirable substance before sealing the mixture and discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sonaflam found in:

A-Z Index: